EB-Plate Is the First Completely Reusable 3D Cell Culture Microplate Launched by eNUVIO

December 8, 2020

EB-Plate, is the first completely reusable 3D cell culture microplate on the market. Scientific research currently consumes high-volumes of single-use plastics – from serological pipettes and pipette tips to vials and culture microplates – these are just a few of the many plastic items thrown in the garbage in labs every day.

eNUVIO’s completely reusable EB-Plate comes to the market at the right time as the demand for 3D cell culture microplates is high, conventional plastic plates are currently in short supply, and the zero-waste movement is becoming increasingly popular in laboratories. As with many emerging environmentally friendly options, it’s no surprise that the reusable and virtually indestructible EB-Plate comes in at a higher cost compared to its plastic counterparts. According to the company, the new plates pay for themselves after approximately 5-8 uses, and can be reused many times more.

eNUVIO* understands the hesitation to switch from tried-and-true devices to new tools, but asserts that in the case of the EB-Plate, scientists don’t have to compromise quality when switching from conventional single-use microplates to a greener choice. This new plate allows researchers to generate embryoid bodies, the necessary first step to growing larger self-assembled 3D cultures known as spheroids or organoids from stem cells. Owing to the unique geometry of each microwell, uniformly-sized spheroids can be generated with high reproducibility, and the high-transmissive plate bottom enables high-quality optical observation. The company anticipates that researchers will benefit from this environmentally-friendly device for a long time, both scientifically and economically.

3D cell cultures are quickly emerging as the next generation tools of choice for safety pharmacology and drug screening purposes. As such, conventional single-use plastic 3D cell culture microplates are increasingly being used in CROs, biotech and pharmaceutical companies as well as for fundamental research in academic and government laboratories. eNUVIO opens the door to researchers around the world to access the first, completely reusable and environmentally-friendly 3D cell culture microplate on the market. The company is banking on labs embracing greener choices in their workflows, and is working to expand their environmentally-friendly product offerings.

EB-PLATE Specifications:

  • 96 microwells/plate
  • Microplate outer dimensions: 127.7 x 85.4 mm
  • Chamber material: Polydimethylsiloxane (PDMS), biologically inert, non-degradable
  • Microplate height (w/o lid): 14.2 mm
  • Microwell opening diameter: 6 mm
  • Microwell diameter at base: 900 µm
  • Microplate bottom thickness: 1 mm
  • Chamber volume: 250 µl
  • Chamber pitch: 9 mm
  • Shipped sterile, ultra-low attachment (ULA) surface
  • In-house production ensures high quality at all times
  • Sold directly through enuvio.com or via scienceexchange.com


“The first step in a new direction is always hard to take, and the EB-Plate finally gives research labs the ability to make a green choice when it comes to embryoid and spheroid generation. There are basically no other green options on the market”, says Mark Aurousseau, CSO and co-founder of eNUVIO, Montreal, Canada.
He continues: “I’ve spoken to many scientists that sometimes just want to use a couple of wells of a plate for an experiment since reagents for this type of research can be quite expensive. They find themselves feeling horrible when they have no option but to throw out a half unused plate.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”